Doshi has established a strong track record in driving quality assurance, regulatory compliance, and formulation excellence across complex pharmaceutical operations
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
Ultra-high purity surfactant for biologics and parenteral drug formulations
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
This is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
The transaction is expected to close in the first quarter of 2022
Subscribe To Our Newsletter & Stay Updated
